Siemens Healthineers, with Operations in Malvern, Enters Distribution Deal for Breast Exam Tech with No Radiation

Siemens Healthineers, the global healthcare technology company with operations in Malvern, has entered into a definitive distribution agreement with UE LifeSciences for the Philadelphia-based company’s flagship product, iBreastExam, writes John George for the Philadelphia Business Journal.

The financial terms of the deal were not disclosed.

Under the partnership, Germany-based Siemens will add iBreastExam to its breast care product portfolio for the U.S. market.

iBreastExam is a hand-held breast examination device that is used during a doctor’s routine clinical breast exam. This battery-powered and wireless device has been cleared by the FDA and is designed to provide documentation and early detection of breast lumps without requiring exposure to radiation.

The device has so far been used in checkups for more than 500,000 women in 10 countries. It has helped diagnose more than 200 cases of breast cancer.

The deal underscores Siemens’ commitment to improving breast cancer-related outcomes by targeting unmet needs in healthcare delivery. That business focus was outlined by Niral Patel, vice president of X-ray products for Siemens Healthineers.

“UE LifeSciences’ iBreastExam clearly addresses a well-defined niche in primary care,” said Patel.

The two companies will begin co-marketing the iBreastExam during the first quarter of 2022.

Read more about the deal in the Philadelphia Business Journal.